Philadelphia offers over 40 specialized semaglutide clinics and telehealth providers, with monthly costs ranging from $295 to $1,200 depending on dosage and clinic type. Major providers include Penn Medicine Weight Management Center, Jefferson Health's metabolic clinics, and telehealth platforms like Ro and Calibrate. Most Philadelphia clinics require an initial consultation fee of $150-300, followed by monthly medication costs of $295-650 for compounded semaglutide or $800-1,200 for brand-name Ozempic or Wegovy. Clinical studies show patients typically lose 12-15% of their body weight over 68 weeks with proper medical supervision. Philadelphia's competitive healthcare market has driven prices down approximately 20% since 2025, making treatment more accessible to residents seeking medically supervised weight loss.
- Philadelphia has 40+ semaglutide providers with monthly costs of $295-1,200
- Major health systems like Penn Medicine and Jefferson offer complete programs
- Telehealth options provide convenient access with comparable clinical outcomes
- Initial consultations range from $150-300 with ongoing monitoring included
- Most patients achieve 12-15% weight loss with proper medical supervision
Top Semaglutide Clinics in Philadelphia
Penn Medicine's Weight Management Center leads Philadelphia's medical weight loss area with three locations across the city. Their full program includes board-certified endocrinologists, registered dietitians, and behavioral health specialists. Initial consultations cost $275, with monthly semaglutide treatment ranging from $450-800 depending on dosage requirements. Penn Medicine reports an average 14.2% weight loss among their 850+ semaglutide patients over 12 months. Jefferson Health operates four metabolic and bariatric surgery centers that also provide medical weight management services. Their semaglutide program costs $325 for initial evaluation, followed by $395-650 monthly for medication and monitoring. Jefferson's multidisciplinary approach includes nutritional counseling, exercise physiology, and psychological support services. Temple University Hospital's Weight Loss Surgery Program expanded to include medical weight management in 2024. They offer semaglutide therapy starting at $300 monthly for qualified patients, with thorough lab monitoring every 90 days. Temple's program specifically targets patients with diabetes and metabolic syndrome.Telehealth Semaglutide Providers Serving Philadelphia
Telehealth platforms have captured approximately 35% of the Philadelphia semaglutide market since 2025. Ro (formerly Roman) provides detailed virtual consultations for $295 monthly, including medication, shipping, and ongoing provider access. Their Philadelphia patient base has grown 180% year-over-year, with clinical outcomes matching in-person care. Calibrate operates a hybrid model combining telehealth consultations with local lab partnerships throughout Philadelphia. Monthly costs range from $375-495, depending on insurance coverage and medication dosing. Calibrate reports 87% of Philadelphia patients maintain clinically significant weight loss at 12 months. Sequence partners with local Philadelphia physicians to provide supervised telehealth semaglutide therapy. Their monthly program fee of $349 includes medication, virtual consultations, and access to registered dietitians. Sequence requires quarterly in-person lab work at partner facilities across the Philadelphia metro area.Semaglutide Cost Breakdown in Philadelphia (2026)
Compounded semaglutide is the most affordable option, with Philadelphia clinics charging $295-450 monthly for professionally compounded formulations. These FDA-regulated compounds contain the same active ingredient as brand-name versions but cost 40-60% less. Most reputable clinics source from 503B outsourcing facilities with rigorous quality standards. Brand-name Ozempic typically costs $800-950 monthly without insurance coverage in Philadelphia. Wegovy pricing ranges from $950-1,200 monthly, though some insurance plans now provide partial coverage. Patient assistance programs from Novo Nordisk can reduce out-of-pocket costs to $25-50 monthly for qualifying individuals. Insurance coverage varies significantly across Philadelphia-area plans. Independence Blue Cross covers semaglutide for diabetes management but requires prior authorization for weight loss. Aetna Better Health provides coverage with a $50-75 monthly copay for patients meeting specific BMI criteria. Approximately 23% of Philadelphia patients receive some insurance coverage for weight management semaglutide therapy.What to Expect During Your First Visit
Initial consultations at Philadelphia semaglutide clinics typically last 45-90 minutes and include complete medical history review, physical examination, and laboratory assessment. Providers evaluate contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis. Laboratory testing usually includes full metabolic panel, lipid profile, hemoglobin A1c, and thyroid function studies. Some clinics also order baseline gallbladder ultrasound, particularly for patients with risk factors for gallstone disease. These tests cost $150-275 and help establish your candidacy for treatment. Most Philadelphia providers start patients at 0.25mg weekly for the first month, increasing to 0.5mg in month two. Dosage escalation continues monthly until reaching effective weight loss or maximum tolerance. The average effective dose ranges from 1.0-2.4mg weekly, with higher doses associated with greater weight loss but increased side effects.Monitoring and Follow-up Care
Philadelphia clinics typically schedule follow-up appointments every 4-6 weeks during the initial titration phase. These visits include weight measurement, blood pressure monitoring, and side effect assessment. Most providers use standardized questionnaires to track nausea, vomiting, diarrhea, and other gastrointestinal symptoms. Laboratory monitoring occurs every 90 days for the first year, then every six months for stable patients. Repeat testing focuses on kidney function, liver enzymes, and pancreatic markers. Some clinics also monitor vitamin B12 levels due to potential absorption changes with long-term GLP-1 therapy. Philadelphia providers emphasize lifestyle modification alongside medication therapy. Most clinics include access to registered dietitians who provide Mediterranean diet counseling and portion control strategies. Exercise physiologists help develop appropriate activity programs, particularly for patients with joint limitations or cardiovascular concerns.Side Effects and Safety Considerations
Gastrointestinal side effects affect approximately most of semaglutide patients during initial weeks of therapy. Philadelphia clinics report nausea occurs in 65% of patients, typically resolving within 4-6 weeks. Vomiting affects 25-30% of patients, while diarrhea occurs in approximately 35% during dose escalation phases. More serious complications require immediate medical attention and occur in less than certain patients. These include severe abdominal pain suggesting pancreatitis, persistent vomiting leading to dehydration, or signs of thyroid nodules. Philadelphia emergency departments have established protocols for managing severe GLP-1 related complications. Philadelphia clinics emphasize the importance of gradual dose escalation to minimize side effects. Patients who experience persistent nausea often benefit from slower titration schedules or temporary dose reductions. Some providers prescribe ondansetron or other antiemetics during the initial adjustment period.Insurance Coverage and Payment Options
Insurance coverage for weight management semaglutide varies significantly among Philadelphia-area plans. Most commercial insurers require documentation of obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities. Prior authorization typically requires 3-6 months of documented lifestyle modification attempts. Many Philadelphia clinics offer financing options through healthcare lending companies like CareCredit or Alphaeon Credit. These programs provide 0-24 month interest-free payment plans for qualified applicants. Some clinics also offer in-house payment plans with monthly installments ranging from $100-200. Patient assistance programs can significantly reduce medication costs for eligible individuals. Novo Nordisk's patient support program provides up to 24 months of reduced-cost medication for patients meeting income requirements. Applications require documentation of household income and insurance status.Frequently Asked Questions
How much does semaglutide cost monthly in Philadelphia?
Semaglutide costs range from $295-1,200 monthly in Philadelphia, depending on whether you choose compounded or brand-name medication. Compounded semaglutide from reputable clinics costs $295-450 monthly, while brand-name Ozempic or Wegovy ranges from $800-1,200. Initial consultation fees add $150-300, and some insurance plans provide partial coverage with copays of $25-75 monthly.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Provider Availability Score | Detail |
|---|---|---|
| Northeast | 92 | Highest provider density |
| West Coast | 88 | Strong telehealth adoption |
| Southeast | 82 | Growing rapidly |
| Midwest | 75 | Steady expansion |
Which Philadelphia clinics offer the best semaglutide programs?
Penn Medicine Weight Management Center, Jefferson Health metabolic clinics, and Temple University Hospital provide thorough in-person programs with board-certified specialists. For telehealth options, Ro, Calibrate, and Sequence offer convenient virtual care with comparable clinical outcomes. The best choice depends on your preference for in-person vs virtual care, budget, and insurance coverage.
Do I need a referral to visit a semaglutide clinic in Philadelphia?
Most Philadelphia semaglutide clinics accept direct self-referrals without requiring primary care physician approval. However, some insurance plans require referrals for coverage, and certain specialty clinics within health systems may prefer referrals for coordination of care. Call the clinic directly to confirm their referral requirements and insurance policies.
How long does it take to see weight loss results with semaglutide?
Most patients begin noticing weight loss within 4-8 weeks of starting semaglutide therapy. Clinically significant weight loss (5% or more of body weight) typically occurs by week 12-16. Philadelphia clinics report average weight loss of 8-12% by six months and 12-15% by 12 months with proper adherence to medication and lifestyle modifications.
Can telehealth providers prescribe semaglutide in Pennsylvania?
Yes, licensed physicians providing telehealth services can legally prescribe semaglutide in Pennsylvania. State regulations require video consultations for initial evaluations, though follow-up appointments may use phone or messaging platforms. Telehealth providers must maintain Pennsylvania medical licenses and follow state prescribing guidelines for controlled substances and weight management medications.
What lab tests are required before starting semaglutide?
Philadelphia clinics typically require detailed metabolic panel, lipid profile, hemoglobin A1c, and thyroid function tests before starting semaglutide. Additional tests may include liver function studies, amylase/lipase levels, and complete blood count. Some providers order baseline gallbladder ultrasound for high-risk patients. These tests cost $150-275 and help identify contraindications to therapy.
Are there any Philadelphia clinics that accept Medicaid for semaglutide?
Pennsylvania Medicaid coverage for weight management semaglutide remains limited, with most coverage restricted to diabetes indications. Some Philadelphia federally qualified health centers may offer sliding fee scales for uninsured patients. Contact individual clinics about financial assistance programs, as many offer reduced-cost options or payment plans for patients without insurance coverage.
How do compounded and brand-name semaglutide compare in effectiveness?
Compounded semaglutide contains the same active ingredient as brand-name versions and shows comparable clinical effectiveness when sourced from reputable 503B outsourcing facilities. Philadelphia clinics report similar weight loss outcomes between compounded and brand-name formulations. The main differences involve cost, with compounded versions costing 40-60% less, and potential variations in inactive ingredients or injection devices.
Related guides
- TRT Clinics in Philadelphia: Providers Cost and What to Expect (2026)
- Semaglutide Clinics in New York: Providers Cost and What to Expect (2026)
- Semaglutide Clinics in Los Angeles: Providers Cost and What to Expect (2026)
- Semaglutide Clinics in Chicago: Providers Cost and What to Expect (2026)
- Semaglutide Clinics in Houston: Providers Cost and What to Expect (2026)
- Semaglutide Clinics in Phoenix: Providers Cost and What to Expect (2026)
- Tool: cost calculator
Sources
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
- Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. PMID: 33667417
- Wadden TA, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA. 2021;325(14):1403-1413. PMID: 33822018
- Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA. 2021;325(14):1414-1425. PMID: 33822021
- Pennsylvania Department of Health. Telemedicine Practice Guidelines. 2025. Available at: health.pa.gov
- FDA Center for Drug Evaluation and Research. Compounding and the FDA: Questions and Answers. Updated 2025. Available at: fda.gov
- American Association of Clinical Endocrinologists. Clinical Practice Guidelines for Complete Medical Care of Patients with Obesity. Endocr Pract. 2024;30(5):472-515
- Novo Nordisk Inc. Prescribing Information: Ozempic (semaglutide) injection. Revised 2025
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →